← Open Payments lookup

KATHRYN DREVETS: Open Payments

NPI 1235551623 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,051 in 42 payments from 11 companies in 2025. Trend: 2023 $470 · 2024 $659 · 2025 $1,051

Food & beverage: $1,051
CompanyPaymentsAmount
Madrigal Pharmaceuticals12$470
Gilead Sciences, Inc.14$261
Ipsen Biopharmaceuticals, Inc4$70
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$67
Takeda Pharmaceuticals U.S.A., Inc.2$58
Davol Inc.1$27
Eton Pharmaceuticals, Inc.1$24
Veloxis Pharmaceuticals, Inc.1$20
Intercept Pharmaceuticals, Inc.1$19
Mirum Pharmaceuticals, Inc.1$19

Products named: REZDIFFRA, IQIRVO, XIFAXAN, LIVTENCITY, GALZIN, ENVARSUS, OCALIVA, Livmarli.

Industry payments across OK — which companies pay providers there.